首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1805篇
  免费   99篇
  国内免费   14篇
耳鼻咽喉   44篇
儿科学   43篇
妇产科学   10篇
基础医学   185篇
口腔科学   1篇
临床医学   139篇
内科学   479篇
皮肤病学   17篇
神经病学   237篇
特种医学   63篇
外科学   424篇
综合类   4篇
预防医学   96篇
眼科学   17篇
药学   56篇
肿瘤学   103篇
  2023年   11篇
  2022年   15篇
  2021年   37篇
  2020年   34篇
  2019年   37篇
  2018年   43篇
  2017年   26篇
  2016年   51篇
  2015年   53篇
  2014年   64篇
  2013年   71篇
  2012年   109篇
  2011年   106篇
  2010年   66篇
  2009年   53篇
  2008年   103篇
  2007年   114篇
  2006年   104篇
  2005年   113篇
  2004年   100篇
  2003年   107篇
  2002年   99篇
  2001年   50篇
  2000年   43篇
  1999年   45篇
  1998年   29篇
  1997年   18篇
  1996年   20篇
  1995年   15篇
  1994年   9篇
  1993年   3篇
  1992年   15篇
  1991年   17篇
  1990年   22篇
  1989年   9篇
  1988年   9篇
  1987年   8篇
  1986年   12篇
  1985年   9篇
  1984年   6篇
  1983年   5篇
  1977年   3篇
  1976年   6篇
  1973年   5篇
  1971年   6篇
  1969年   2篇
  1968年   4篇
  1967年   2篇
  1966年   5篇
  1965年   5篇
排序方式: 共有1918条查询结果,搜索用时 12 毫秒
21.
22.
Growth cones are known as the site of action of many factors that influence neurite growth behavior. To assess how different collapsing agents influence the growth cone cytoskeleton, we used recombinant human Semaphorin III (hSema III) and the serine protease thrombin. Embryonic chick dorsal root ganglion neurons showed a dramatic depolymerization of actin filaments within 5 min upon hSema III exposure and virtually no influence on microtubules (MT). Only at later time points (20-30 min) was the polymerization/depolymerization rate of MT significantly affected. Thrombin induced a morphologically and kinetically similar growth cone collapse. Moreover, thrombin induced an early and selective depolymerization of dynamic MT, accompanied by the formation of loops of stable MT bundles. Selective changes in the phosphorylation pattern of tau were associated with microtubule assembly in thrombin-induced responses. Our data provide evidence that different signal transduction pathways lead to distinct changes of the growth cone cytoskeleton.  相似文献   
23.
Two phase I vaccine trials were conducted to test the immunogenicity and safety of a vaccine containing three recombinant malaria antigens from the asexual stage of Plasmodium falciparum. The three antigens are a fragment of MSP1 (190LCS.T3); MSP2 and a portion of RESA and were formulated in Montanide ISA720 adjuvant. These trials investigated the dose response of each antigen for eliciting both antibody and T-cell responses and the immunogenicity of a mixture of the antigens compared with the antigens injected separately. All three antigens elicited both antibody and T-cell responses. Strong T-cell responses were observed with 190LCS.T3 and RESA with stimulation indices exceeding 100 for peripheral blood leucocytes in some individuals. The antibody responses were generally weak. The human antibody responses observed with MSP2 in Montanide ISA720 were not significantly different from those obtained in an earlier trial which used MSP2 with alum as the adjuvant. No antigenic competition was observed: volunteers receiving a mixture of antigens had similar responses to those receiving the three antigens at separate sites. Tenderness and pain at the injection site were common over the first few days following immunization. In some volunteers, especially those receiving the highest doses tested, there was a delayed reaction at the injection site with pain and swelling occurring approximately 10 days after injection.  相似文献   
24.
25.
The compartment syndrome is an extremely rare complication after varicose vein surgery. If the early symptoms are not recognized and a treatment is not performed immediately most patients lose sensomotory function. Three cases with compartment syndrome after varicose vein stripping were the reason to point out the anatomy and pathophysiology of this complication and to explain the surgical technique.  相似文献   
26.
Esther Molina‐Montes  María‐Jos Snchez  Raul Zamora‐Ros  H.B Bueno‐de‐Mesquita  Petra A. Wark  Mireia Obon‐Santacana  Tilman Kühn  Verena Katzke  Ruth C. Travis  Weimin Ye  Malin Sund  Alessio Naccarati  Amalia Mattiello  Vittorio Krogh  Caterina Martorana  Giovanna Masala  Pilar Amiano  Jos‐María Huerta  Aurelio Barricarte  Jos‐Ramn Quirs  Elisabete Weiderpass  Lene Angell sli  Guri Skeie  Ulrika Ericson  Emily Sonestedt  Petra H. Peeters  Isabelle Romieu  Augustin Scalbert  Kim Overvad  Matthias Clemens  Heiner Boeing  Antonia Trichopoulou  Eleni Peppa  Pavlos Vidalis  Kay‐Tee Khaw  Nick Wareham  Anja Olsen  Anne Tjnneland  Marie‐Christine Boutroun‐Rualt  Franoise Clavel‐Chapelon  Amanda J. Cross  Yunxia Lu  Elio Riboli  Eric J. Duell 《International journal of cancer. Journal international du cancer》2016,139(7):1480-1492
Despite the potential cancer preventive effects of flavonoids and lignans, their ability to reduce pancreatic cancer risk has not been demonstrated in epidemiological studies. Our aim was to examine the association between dietary intakes of flavonoids and lignans and pancreatic cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort. A total of 865 exocrine pancreatic cancer cases occurred after 11.3 years of follow‐up of 477,309 cohort members. Dietary flavonoid and lignan intake was estimated through validated dietary questionnaires and the US Department of Agriculture (USDA) and Phenol Explorer databases. Hazard ratios (HR) and 95% confidence intervals (CIs) were calculated using age, sex and center‐stratified Cox proportional hazards models, adjusted for energy intake, body mass index (BMI), smoking, alcohol and diabetes status. Our results showed that neither overall dietary intake of flavonoids nor of lignans were associated with pancreatic cancer risk (multivariable‐adjusted HR for a doubling of intake = 1.03, 95% CI: 0.95–1.11 and 1.02; 95% CI: 0.89–1.17, respectively). Statistically significant associations were also not observed by flavonoid subclasses. An inverse association between intake of flavanones and pancreatic cancer risk was apparent, without reaching statistical significance, in microscopically confirmed cases (HR for a doubling of intake = 0.96, 95% CI: 0.91–1.00). In conclusion, we did not observe an association between intake of flavonoids, flavonoid subclasses or lignans and pancreatic cancer risk in the EPIC cohort.  相似文献   
27.
28.
Introduction The study analyzes and interprets possible effects of the COVID-19 pandemic on the preterm birth rate. Research questions included: were there fewer preterm births in Berlin in 2020, the first year of the pandemic, compared to the three years before the pandemic? Were there differences in preterm birth rates grouped according to weeks of gestation? Method The perinatal data of all singleton pregnancies were evaluated with regard to birth rates in Berlin, and the numbers of preterm neonates born in the three pre-pandemic years from 2017 to 2019 were compared to the rate for 2020, the first year of the pandemic. Results The overall number of singleton pregnancies born in maternity hospitals and labor wards in Berlin decreased in the first year of the pandemic. The percentage of preterm neonates born before 37 + 0 weeks of gestation (GW) was significantly lower in 2020 compared to the three previous years, with significantly more preterm neonates born before 28 + 0 GW and significantly fewer preterm neonates born between 28 + 0 to 35 + 0 GW. In 2020, significantly fewer neonates born before 37 + 0 weeks of gestation were delivered by primary caesarean section. The incidence of induced births was approximately the same. Conclusions In the first year of the pandemic, a range of social, iatrogenic, and biological factors may have had an impact on preterm birth rates. A Germany-wide evaluation of perinatal data across different German federal states for the period 2020 to 2022 would offer the opportunity to identify the causes of this lower rate of preterm births and determine whether conclusions can be drawn from this which would affect future strategies to reduce preterm birth rates.  相似文献   
29.
30.
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号